Market Cap | ₹46,440Cr |
ROE | 47.54% |
P/E Ratio(TTM) | 48.87 |
EPS(TTM) | 56.09 |
P/B Ratio | 23.80 |
Dividend Yield | 1.97% |
Industry P/E | 34.99 |
Book Value | 115.19 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | GlaxoSmithKline Pharmaceuticals Limited |
Managing Director | Mr. Bhushan Akshikar |
NSE Symbol | GLAXO |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 43.61 | ||
Pfizer | NA (0.00%) | 30.33 | ||
Astrazeneca Pharma India | NA (0.00%) | 124.91 | ||
Sanofi Consumer Healthcare India | NA (0.00%) | 53.90 |